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To study European bat lyssavirus (EBLV) in bat reser-
voirs in the Netherlands, native bats have been tested for
rabies since 1984. For all collected bats, data including
species, age, sex, and date and location found were
recorded. A total of 1,219 serotine bats, Eptesicus seroti-
nus, were tested, and 251 (21%) were positive for
lyssavirus antigen. Five (4%) of 129 specimens from the
pond bat, Myotis dasycneme, were positive. Recently
detected EBLV RNA segments encoding the nucleoprotein
were sequenced and analyzed phylogenetically (45 speci-
mens). All recent serotine bat specimens clustered with
genotype 5 (EBLV1) sequences, and homologies within
subgenotypes EBLV1a and EBLV1b were 99.0%–100%
and 99.2%–100%, respectively. Our findings indicate that
EBLVs of genotype 5 are endemic in the serotine bat in the
Netherlands. Since EBLVs can cause fatal infections in
humans, all serotine and pond bats involved in contact inci-
dents should be tested to determine whether the victim was
exposed to EBLVs.
European bat lyssaviruses (EBLVs) belong to theLyssavirus genus of the Rhabdoviridae family and
form a group of negative single-stranded RNA viruses with
an almost worldwide distribution. The genus Lyssavirus
can be divided into 7 genotypes, including EBLV1 as
genotype 5 and EBLV2 as genotype 6 (1). EBLVs have
been demonstrated in several bat species, and more bat
species may be susceptible. The bite of an EBLV-infected
bat may cause fatal encephalitis in humans; 4 fatal human
cases have been reported. Three of the 4 viruses were
typed genetically to be definitely EBLV (2). The most
recent case was a 56-year-old bat worker in Scotland who
was thought to have been bitten on his hand by a
Daubenton’s bat (3). Therefore, bat rabies is considered a
public health threat in countries where these viruses are
endemic in bats. In the Netherlands, genotype 1 lyssavirus-
es were eradicated in the early 1990s, but EBLVs are
endemic in several bat species; the serotine bat, Eptesicus
serotinus, is considered the main reservoir of rabies in this
country. If possible, bats involved in contact incidents are
sent to the Central Institute for Animal Disease Control
(CIDC), Lelystad, to be tested for lyssavirus. Rabies diag-
nosis is always performed within 24 hours and if neces-
sary, rabies postexposure prophylaxis is administered to
the patient according to World Health Organization recom-
mendations.
To provide a picture of rabies incidence and distribution
in native bat species in the Netherlands, data for bats test-
ed for lyssavirus antigen at CIDC-Lelystad were collected
and analyzed. To characterize the circulating EBLVs,
reverse transcription–polymerase chain reaction (RT-PCR)
amplification products of EBLV RNA were sequenced and
analyzed phylogenetically. 
Materials and Methods
Bat Specimens and Bat Data 
In the Netherlands, surveillance of lyssaviruses in bats
is ongoing. In 1984, it became mandatory to submit bats
caught by animals or bats that were unable to fly to the
CIDC-Lelystad Department of Virology for lyssavirus
antigen testing. After 1987, surveillance began nationwide;
since 1994, mainly bats involved in contact incidents and
suspected of rabies infection have been submitted for test-
ing. As part of this surveillance, from 1984 to 2003, brain
tissue samples were collected from all submitted bats.
Each year, >100 of these animals were tested for lyssavirus
antigen. The locations where the bats were found were
plotted by using 5 × 5 km grid allocations. In addition to
location and date found, species, sex, and age were deter-
mined and recorded (by P.H.C.L.). 
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The number of EBLV-positive bats was described by the
binomial distribution prevalence that was specific to each
sex-age group. This distribution produced a sequence of
nested binomial models to test the effect of adding an extra
group-specific prevalence to a simpler model by the likeli-
hood ratio test. If the resulting deviance was greater than
the 95th percentile of the chi-square distribution with 1
degree of freedom, the prevalence of the sex-age group was
considered to be significantly different from the others.
Detection of Lyssavirus Antigen
Detection of lyssavirus antigen was performed by stan-
dard fluorescent antibody test (FAT) as described (4), with
modifications, using polyclonal fluorescein isothio-
cyanate–labeled rabbit anti-rabies nucleocapsid
immunoglobulin G (IgG) (Diagnostics Pasteur, Marnes-la-
Coquette, France). Positive controls, brain tissue smears
from mice infected with genotypes 1 and 5 field virus,
were incorporated in each test run. Duplicate smears were
carefully and completely checked for fluorescence. From
1997 to 2003, all test results that were positive by FAT (n
= 45) were confirmed by RT-PCR and sequenced. 
RT-PCR Analyses
To amplify EBLV-specific RNA, brain tissue samples
(3 mm3) were put in 0.5 mL RNA extraction buffer. The
RNA extraction was performed by using TRIzol
(Invitrogen Life Technologies, Merelbeke, Belgium)
according the manufacturer’s protocol. TRIzol was added
to the brain tissue sample to a total volume of 1.0 mL. RT-
PCR amplification was performed as described (5). Primer
selection and Southern blot hybridizations of RT-PCR
products were performed as described (6). To characterize
the EBLVs, RT-PCR amplification products of all FAT-
positive samples collected from 1997 to 2003 were con-
firmed by RT-PCR and sequenced later.
EBLV RNA Sequence Analyses
Direct sequencing of the RT-PCR-amplified products of
a 566-nucleotide (nt) fragment coding for the amino termi-
nus of the nucleoprotein of EBLV and analyses of the
nucleotide sequences were performed as described (7).
This part of the genome was used to enable a comparison
with sequences described by other lyssavirus researchers
in Europe (7). PCR fragments were purified by QIAquick
Purification Kit (Qiagen, Hilden, Germany) and then
sequenced directly on both strands. Sequencing was per-
formed on a Biosystems (ABI) 3700 DNA automated
sequencer (Perkin Elmer-Applied Biosystems, Foster City,
CA, USA) by using fluorescent dye–labeled dideoxynu-
cleo terminators (BigDye Terminator Cycle Sequencing
Ready Reaction, Perkin Elmer-Applied Biosystems,
Warrington, UK). Nucleotide sequences were edited by
using Seq Ed (V1.03, Applied Biosystems), and aligned
using Bionumerics (V2.5) (Applied Maths, Kortrijk,
Belgium). To compare detected and historic sequences,
phylogenetic trees were created based on cluster analyses
and global alignment similarities of 396 nucleotide frag-
ments of the N-gene encoding region (position in the
genome nucleotide 46–441, numbered according to the
CVS strain, GenBank accession no. D42112). The confi-
dence values of the internal nodes were calculated by per-
forming 100 bootstrap analyses (Bionumerics V2.5). 
To allow the geographic relationship between homolo-
gous strains to be studied, sequences showing a high
sequence homology were grouped by “cluster”. All
sequence “cluster” numbers were positioned on the coun-
try map to determine if sequences with high homogeneity
originated from the same region.
Results
Detection of Lyssavirus Antigen
From 1984 to 2003, bats of 1 vagrant and 11 native
species (Table 1) were tested for lyssavirus antigen.
Lyssavirus was detected in 2 species only, the serotine bat
and the pond bat, Myotis dasycneme. A total of 1,219 sero-
tine bats and 129 pond bats were tested for lyssavirus anti-
gen; 251 serotine bats and 5 pond bats were positive,
which results in 21% and 4% prevalence, respectively. In
the most common native bat species, the pipistrelle,
Pipistrellus pipistrellus, EBLV was never detected (1,837
specimens tested). Approximately one third (32%) of all
bats submitted for lyssavirus antigen testing were serotine
bats (Table 1, Figure 1).
EBLV RT-PCR and RNA Sequence Analyses
All FAT-positive bat brain tissue samples collected
from 1997 to 2003 tested positive by PCR. Direct sequenc-
ing of the RT-PCR–amplified products of a 566-nt coding
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region of the amino terminus of the nucleoprotein resulted
in homologies within subgenotypes EBLV1a (41 speci-
mens) and EBLV1b (4 specimens) of 99.0%–100% and
99.2%–100%, respectively. Homologies with older EBLV
bat isolates from the Netherlands were also within these
ranges. Phylogenetic analyses did not show a significant
change or shift in EBLV nucleoprotein encoding
sequences over the years (Figures 2 and 3).
Geographic Distribution, Age, and Sex
The geographic origin of tested and EBLV-positive
serotine and pond bats are depicted in Figures 4 and 5,
respectively. The numbers of tested and EBLV-positive
serotine bats per year are shown in Figure 1. High homol-
ogy sequences detected in serotine bats did not show a
clustering per year (Figure 2), but EBLV sequences that
showed a high degree of homology seemed to have a geo-
graphic relationship for at least 2 lineages (clusters 2 and
4, Figure 3). Regarding age and sex, a significantly higher
number of EBLV-infected serotine bats were found in the
group of adult females, 25% EBLV positives (Table 2).
Discussion
From 1984 to 2003, the serotine bat appeared to be the
main wildlife reservoir of EBLVs in the Netherlands, as in
several other European countries (7). European bat
lyssavirus incidence in serotine bats in the Netherlands
was 21%. A much lower incidence of 4% was found in the
pond bat. In the Netherlands, females of both the serotine
bat and the pond bat usually dwell as maternity colonies in
the summer; single males or male groups dwell in walls of
houses and other buildings and occasionally in suitably
quiet spaces like church lofts.
These practices may bring humans and pets in contact
with diseased bats. Among pets, cats are the most common
predators of building-dwelling bats. Most of the bats sub-
mitted for testing were prey of cats, many of the bats had
been in direct contact with humans, and only a few were
involved in biting incidents. Most of these bats were
assumed to be diseased or exhausted, and therefore, the
observed EBLV incidences in both bat species almost cer-
tainly are an overestimation of the incidence in healthy bat
populations in the Netherlands. EBLV-positive cats were
never identified, so the risk of infection seems to be very
low for cats involved in bat contact.
The difference in the overall prevalence between the
serotine bat and the pond bat is difficult to explain. The
serotine bat and the pond bat are not related species.
Differences in behavior or sensitivity to EBLV infection or
disease may be underlying causes for the observed differ-
ences in EBLV prevalence in the 2 species. The patho-
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Figure 1. Number of submitted and lyssavirus antigen–positive
samples from serotine bats, Eptesicus serotinus, collected in the
Netherlands during the survey (1984–2003). 
Figure 2. Phylogenetic tree of European bat lyssavirus (EBLV1)
sequences detected in serotine bats in the Netherlands,
1997–2003, and historic EBLV sequences detected in bats in
Europe. Tree calculated based on cluster analyses and global
alignment similarities of 396 nucleotide fragments of the N-gene
encoding region (position in the genome nucleotide 46–441, num-
bered according to the CVS strain, GenBank accession no.
D42112). The confidence values of the internal nodes were calcu-
lated by performing 100 bootstrap analyses.
genicity of EBLVs in natural hosts has not been extensive-
ly studied because bats are legally protected in most
European countries (European Commission Directive
92/43/EEC on the Conservation of Natural Habitats and of
Wild Fauna and Flora, 1992). Some European countries
have even more strict regulations than those described in
the European directive. Due to strict regulations on
wildlife conservation in some countries, the study of
EBLV infections in bats is hampered. Therefore, whether
EBLVs normally cause fatal infections or induce an
asymptomatic infection and virus persistence in individual
bats is not known (8). Another possibility is that EBLVs
induce infection with a long incubation period (i.e.,
months, years), because this can also lead to long-term
maintenance of the virus within a specific species. Studies
to elucidate this issue have not shown exclusive results (6).
Apart from the species, data including age, sex, and
dates and locations the bats were found were also docu-
mented; these data enable us to show a clear picture of the
geographic distribution of EBLVs in different bat species
in the Netherlands (Figures 4A and B and Figure 5) for the
first time. The serotine bat is relatively common and can be
found throughout the country. The species is especially
numerous in the northwest. In the south, the species is
present almost everywhere but in rather low numbers. The
pond bat is fairly common in the north and west. Both
serotine bats and pond bats submitted for EBLV testing
were concentrated more in the northern and the middle part
of the country. This finding indicates the summer distribu-
tion and population density of both species in the
Netherlands (9). During winter, the serotine bat hibernates
individually or in small groups in cavity walls of buildings
usually not far from its summer roosts. The pond bat
migrates to subterranean winter roosts which may be
20–300 km from its summer roosts. Hibernation of the
pond bat in cavity walls of buildings has not yet been
observed. The higher number (25%) of EBLV infections
observed in adult female serotine bats is not surprising
because adult females of this species live close together
during their maternity period in the summer.
Forty-five FAT-positive bat brain tissue samples select-
ed for EBLV sequence analysis tested positive by PCR. For
these samples, the EBLV RT-PCR assay proved to be at
least as sensitive as the FAT test system that is used for
EBLV surveillance. Sequencing the RT-PCR-amplified
products of the nucleoprotein-encoding region and subse-
quent sequence analyses resulted in exclusively EBLV1
subgenotype lineages. EBLV1a isolates showed a
99.0%–100% homology, whereas EBLV1b isolates in the
Netherlands showed a 99.2%–100% homology. Homo-
logies with older EBLV isolates from the Netherlands were
also within these ranges (Figures 2 and 3).
Sequences from serotine bats with high homology for at
least 2 EBLV1a lineages (clusters 2 and 4, Figure 3) orig-
inated from a defined geographic region in the
Netherlands. This observation suggests that transmission
of EBLVs in serotine bats over long distances within the
country does not seem to play a major role in EBLV epi-
demiology. However, Davis et al. (10) recently suggested
that transmission viral traffic may be established among
bats in northern Europe because high homology strains
were found across this entire region. For the EBLV1b lin-
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Figure 3. A) Phylogenetic tree of European bat lyssavirus 1 (EBLV1) sequences detected in serotine bats in the Netherlands, 1997–2003,
and some historic sequences detected in bats in Europe. Analysis performed with maximum parsimony of representative DNA sequences
of different EBLV1 sequences. B) Relationships between 7 different serotine bat EBLV1a sequence lineages (numbered “clusters” 1 to
7): maximum parsimony unrooted tree of representative EBLV1 sequences detected in serotine bats in the Netherlands and several his-
toric sequences detected in other European countries (color coded country). C) Geographic distribution of the 7 different serotine bat
EBLV1 lineages (numbered “clusters” 1 to 7) from 41 recently detected serotine bat isolates in the Netherlands.
eages, the possibility of geographic clustering of high
homology sequences could not be determined because of
the relatively low number of analyzed sequences.
EBLV sequences detected in native bats in the
Netherlands showed little divergence and did not indicate
an emergence of new EBLV strains, but this study con-
firms that the serotine bat is an EBLV1 reservoir. Since at
least 4 fatal EBLV infections have been reported in
humans in Europe in the last decade, the public health haz-
ard of bat rabies in Europe should not be underestimated.
Any contact with bats in Europe must be considered possi-
ble exposure, and biting incidents should be treated imme-
diately with rabies postexposure prophylaxis. If possible,
the involved bat should always be kept for lyssavirus test-
ing. To prevent rabies transmission from bats, all bat han-
dlers should be informed of the risks of rabies exposure
and advised to be vaccinated. The continuing prevalence
of EBLVs in serotine bats and pond bats in Europe and the
risk of a fatal infection in humans should compel European
countries to work together on bat lyssavirus surveillance.
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Figure 5. Location of pond bat, Myotis dasycneme, with positive
(triangles) and negative (dots) test results for European bat
lyssaviruses, the Netherlands, 1984–2003.
Figure 4. Location of serotine bat, Eptesicus serotinus, with posi-
tive (triangles) and negative (dots) test results for European bat
lyssaviruses, the Netherlands; A)1984–1989; B)1990–2003. 
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